71 search results for lung cancer
NCCN Guidelines for Patients with Permission Email
Myeloid Leukemia Colon Cancer Esophageal Cancer Head and Neck Cancers: Nasopharyngeal Cancer Oral Cancers Oropharyngeal Cancer Hepatobiliary Cancers: Liver Cancer Gallbladder and Bile Duct Cancers Hodgkin Lymphoma Kidney Cancer Lung Cancer: Early and Locally Advanced Metastatic Malignant, e a a n d Vomiting Cancer Screening Lung Cancer Screening Age-Related Adolescents and Yo u n g, Invasive Metastatic Colon Cancer Kidney Cancer Lung Cancer: Early and Locally Advanced
https://www.nccn.org/docs/default-source/patient-resources/nccn-guidelines-for-patients-with-permission-email.pdf?sfvrsn=94769ebd_2Transparency Process
/Attendance Adult Cancer Pain Panel Version: 1.2025 ( Adult Cancer Pain ) Date: 2024-09-19 Transparency Panel Disclosures/Attendance Version: 2.2024 ( Adult Cancer Pain ) Date: 2024-03-06 Transparency Panel Disclosures/Attendance Version: 1.2024 ( Adult Cancer Pain, ( Adult Cancer Pain ) Date: 2022-09-12 Transparency Panel Disclosures/Attendance
https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendationsGuidelines for Patients
Version: 2023 Lung Cancer Screening, Non-Small Cell Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic, Small Cell Lung Cancer Version: 2024, Cancer Version: 2023 Adrenal Tumors
https://www.nccn.org/guidelines/patientsTreatment by Cancer Type
Treatment by Cancer Type, Version: 1.2025 Non-Small Cell Lung Cancer, Small Cell Lung Cancer Version: 4.2025, . NCCN Guidelines Treatment by Cancer Type, Version: 3.2025 Basal Cell Skin Cancer, Version: 2.2025 Biliary Tract Cancers
https://www.nccn.org/guidelines/category_1PAS Policy Report Precision Medicine Final
for the appropriate biomarker tests. Lung and other cancers require significant surgical intervention, and Implications for Quality, Accessible, and Equitable Cancer Care In recent years, targeted medicines have offered dramatic advancements in cancer care outcomes across a wide variety of cancer types. However, as cancer care becomes increasingly personalized, access to biomarker testing and targeted, , the National Comprehensive Cancer Network (NCCN ® ) conducted a patient advocacy scan
https://www.nccn.org/docs/default-source/oncology-policy-program/pas-policy-report-precision-medicine-final.pdf?sfvrsn=468e4a2b_1Webinars for Patients
Small Cell Lung Cancer (2025) Why Should I Consider a Clinical Trial? (2025) Non-Small Cell Lung Cancer (NSCLC) (2025) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (2024) Myeloproliferative Neoplasms (MPN) (2024) Breast Cancer Screening (2024) Advanced and Metastatic Bladder, , patient resources, breast cancer, lung cancer, recorded webinars, recorded patient webinar, myeloma, NCCN provides free webinars for people affected by cancer and caregivers. These live
https://www.nccn.org/patientresources/patient-resources/patient-webinarsSubmission Request Form
- 2.2025 B-Cell Lymphomas - 2.2025 Biliary Tract Cancers - 1.2025 Bladder Cancer - 1.2025 Bone, System Cancers - 5.2024 Cervical Cancer - 4.2025 Chronic Lymphocytic Leukemia/Small Lymphocytic, and Esophagogastric Junction Cancers - 3.2025 Gastric Cancer - 2.2025 Gastrointestinal Stromal Tumors, Kaposi Sarcoma - 2.2025 Kidney Cancer - 3.2025 Lung Cancer Screening - 1.2025 Management, - 1.2025 Neuroendocrine and Adrenal Tumors - 1.2025 Non-Small Cell Lung Cancer - 3.2025 Occult
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-formAsia
practice guidelines for the treatment of lung cancer for patients in Vietnam. Moving forward, the groups, nccnchina.org.cn Chinese Gynecologic Cancer Society (CGCS): In collaboration with the Chinese Gynecologic Cancer Society (CGCS) and Shanghai Yanxin Cultural Firm, NCCN will work with the leading cancer care experts in China to translate and adapt NCCN Guidelines for Gynecologic Cancers, including cervical Cancer, Ovarian Cancer, Uterine Neoplasms, Gestational Trophoblastic Neoplasia, and Vulvar
https://www.nccn.org/global/global-program/asiaAbout the NCCN Guidelines for Patients
than 25 years, the National Comprehensive Cancer Network® (NCCN®) has developed resources to improve the quality of cancer care. These resources include the award-winning NCCN Guidelines for Patients, discuss options with their cancer care team. This library of free resources is made possible through, for their ability to empower people with cancer and caregivers. Recent Awards, Annual Communicator Award of Distinction for the NCCN Guidelines for Patients: Kidney Cancer
https://www.nccn.org/patientresources/patient-resources/about-the-nccn-patient-guidelinesChemotherapy Order Templates Reviewer Acknowledgement
Fred & Pamela Buffett Cancer Center Biliary Tract Cancers, Fred Hutchinson Cancer Center Esophageal and Esophagogastric Junction Cancers, , BCOP Mayo Clinic Comprehensive Cancer Center Non-Small Cell Lung, Moores Cancer Center Pediatric Central Nervous System Cancers, Institute at the University of Utah Small Cell Lung Cancer Sally
https://www.nccn.org/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagement30 Years of NCCN
for the treatment of cancer and perform outcomes research – and so the NCCN was born. With 13 original NCCN Member, with cancer across the country. Now an alliance of 33 leading cancer centers, NCCN develops resources, as a national alliance to develop and institute standards of care for the treatment of cancer and perform, published to assist in the decision-making process of individuals involved in cancer care to improve patient care and outcomes. The first disease types available were: Acute Leukemia and Breast, Colon, Lung
https://www.nccn.org/home/about/nccn-history/30-years-of-nccnYoung Investigator Awards
to Improve Lung Cancer Screening Among Black Veterans Ravi Parikh, MD, MPP, The Abramson, . News Details The National Comprehensive Cancer Network® (NCCN, NCCN Member Institutions represent tomorrow’s leaders for advancing cancer care. The NCCN Oncology, -Farber/Brigham and Women’s Cancer Center | Mass General Cancer Center A Phase II Sudy of Response, Cancer (SG) – NeoSTAR A2 Cohort Mathew Angelos, MD, PhD, University of Colorado Cancer CenterA
https://www.nccn.org/education-research/nccn-oncology-research-program/young-investigator-awardsYoung Investigator Awards
Comprehensive Cancer Center Novel Combination Therapy for Colorectal and Esophagogastric Cancers Zachary, Neelima Navuluri, MD, MPH, Duke Cancer Institute Intervention Mapping to Improve Lung Cancer, The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® each, tomorrow’s leaders for advancing cancer care. The NCCN Oncology Research Program (ORP) manages, . Recent YIA Recipients 2025 Rachel Abelman, MD, Dana-Farber/Brigham and Women’s Cancer
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/young-investigator-awardsThe Impact of Policy Regulation on Guideline-Concordant Care Globally Summary Article
specific cancers. One significant step to reduce cancer incidence is to eliminate tobacco usage, based on the WHO EML for cancers with the highest incidence in LLMICs. These cancers include lung, of patients with cancer lack access to essential medicines, crucial health infrastructure, and coordinated multidisciplinary cancer care. One path forward is an active effort from policymakers, cancer types and standardization of care through clinical practice guidelines in oncology. Moreover
https://www.nccn.org/docs/default-source/global/the-impact-of-policy-regulation-on-guideline-concordant-care-globally-summary-article.pdf?sfvrsn=b36df21a_3Advocacy December Toolkit_2021
Cholangiocarcinoma Foundation 4 Fight Colorectal Cancer 6 GO2 Foundation for Lung Cancer 7 ICAN, NCCN Digital Booklet of Patient Advocacy Resources National Comprehensive Cancer Network, , A c c e s s i b l e , a n d Equitable Cancer Care The NCCN Digital Resource Booklet includes, to precision medicine and address related needs for people with cancer. This Booklet was developed in conjunction with The National Comprehensive Cancer Network’s ® (NCCN ® ) Virtual Patient
https://www.nccn.org/docs/default-source/oncology-policy-program/advocacy-december-toolkit_2021.pdf?sfvrsn=4c2c60da_1NCCN_Oncology_Research_Program_Brochure
of patients with suspected or newly diagnosed lung cancer in Antelope Valley, one of the most underserved regions of Southern California. Antelope Valley has the highest rate of lung cancer mortality, of the first lung cancer screening program in Antelope Valley. This initiative has touched many, and treatment of lung cancer in this underserved area.” Dan J. Raz, MD City of Hope National Medical Center, that improve the lives of patients with cancer. National Comprehensive Cancer Network® Namrata Vijayvergia
https://www.nccn.org/docs/default-source/oncology-research-program-(orp)/nccn_oncology_research_program_brochure.pdf?sfvrsn=ebab0181_3NCCN Guidance on Inclusive Language
cancer rather than a lung cancer patient ). An illness or disease is something individuals have (ie, Language Guide. International Association for the Study of Lung Cancer; 2021. Available at: https, Version 2.0 | April 25, 2025 © 2025 National Comprehensive Cancer Network® (NCCN®) NCCN, Guidance Version 2.0 April 25, 2025 Page 2 of 10 © 2025 National Comprehensive Cancer Network, Version 2.0 April 25, 2025 Page 3 of 10 © 2025 National Comprehensive Cancer Network® (NCCN
https://www.nccn.org/docs/default-source/about/nccn-guidance-on-inclusive-language.pdf?sfvrsn=53c8c78f_2Detection, Prevention, and Risk Reduction
Lung Cancer Screening Version: 1.2025 Prostate Cancer Early Detection Version: 1.2025, ®) are posted with the latest update date and version number. Breast Cancer, Cancer Screening and Diagnosis Version: 2.2025 Colorectal Cancer Screening Version: 1.2024
https://www.nccn.org/guidelines/category_2Calendar of Events
to the Management of Resectable Non-Small Cell Lung Cancer Earn CE credit. EVENT, Inhibition in Breast Cancer: Expert Perspectives on Integrating Guideline Updates and Recent Advances, and the Cancer Burden Globally Not a CE-certified activity. EVENT DETAILS, Options in Upper Gastrointestinal Cancers Earn CE credit. EVENT DETAILS, Intelligence Landscape in Cancer Care Not a CE-certified activity. | Virtual attendance also
https://www.nccn.org/education-research/educational-events-and-programs/calendar-of-eventsGuidelines With Evidence Blocks
2.2025 Central Nervous System Cancers Version 5.2024 Cervical Cancer Version, Neuroendocrine and Adrenal Tumors Version 1.2025 Non-Small Cell Lung Cancer, Version 2.2025 Small Bowel Adenocarcinoma Version 3.2025 Small Cell Lung Cancer, AND DEFINITIONS © National Comprehensive Cancer Network® The goal is to provide the health care provider, more about submission requests. NCCN Evidence Blocks™ User Guide In cancer care, the most
https://www.nccn.org/guidelines/guidelines-with-evidence-blocks